Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Medical Expulsion Therapy of Ureteral Stones
NCT00713739Phase 3Unknown
- Sponsor
- Naval Medical Center San Diego
- Start
- Jan 2008
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of alfuzosin in ureteral stone (4 arms), sponsored by Naval Medical Center San Diego. Primary endpoints: Percent of stones passed at 30 days, Rates of occurrence of various side effects at 30 days and 3 more. Status: unknown.
02
Drugs
alfuzosin
03
Conditions
ureteral stone
Beyond the preview
Go deeper on NCT00713739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713739.